Jim Flatt, Ph.D. Chief Executive Officer DMC Biotechnologies Dr. Jim Flatt brings over three decades of leadership in the biotechnology and renewable products industries to DMC Biotechnologies. With a Ph.D. in Chemical Engineering from the University of Wisconsin and advanced degrees from UC Berkeley and MIT, Jim has a proven track record of innovation in bioactives, precision fermentation, and sustainable solutions. He co-founded Brightseed, where he pioneered AI-driven health ingredient discovery and led the company to commercial success, securing over $125M in funding. His leadership spans roles at Synthetic Genomics, Martek Biosciences, and Monsanto, where he successfully scaled and commercialized novel technologies. Jim's expertise in biotechnology, product development, and strategic growth positions him to lead DMC into its next phase of impactful innovation.

‍